Evidence map›Paper›PMID 41226525›Full record

ArticleInternational journal of molecular sciences2025

Long Noncoding RNA Lnc-MTPAP-1 Overexpressed by Particulate Matter Suppresses Apoptosis in Non-Small Cell Lung Cancer (NSCLC) Cells.

Ji Won Park, Daeun Kang, Min Hyeok Lee, Yeonwoo Lee, Su Yel Lee, Sin Yung Woo, Keum-Jin Yang, In Beom Jeong, Hee Sun Park, Ji Woong Son and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ji Won ParkDivision of Pulmonology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon 16247, Republic of Korea.
Daeun KangDivision of Pulmonology, Department of Internal Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.ORCID 0000-0002-1449-8757
Min Hyeok LeeDivision of Pulmonology, Department of Internal Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.ORCID 0000-0002-0098-8106
Yeonwoo LeeMyunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.
Su Yel LeeMyunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.ORCID 0000-0001-5800-1389
Sin Yung WooDivision of Endocrinology, Department of Internal Medicine, Konyang University Hospital, Daejeon 35365, Republic of Korea.ORCID 0000-0001-6643-9751
Keum-Jin YangClinical Research Institute, Daejeon St. Mary's Hospital, Daejeon 16247, Republic of Korea.
In Beom JeongDivision of Pulmonology, Department of Internal Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.
Hee Sun ParkDivision of Pulmonology and Allergy, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea.
Ji Woong SonDivision of Pulmonology, Department of Internal Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.
Sun Jung KwonDivision of Pulmonology, Department of Internal Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.

Funding

Catholic University of Korea, Daejeon St. Mary's Hospital Clinical Research Institute CMCDJ-P-2023-008Konyang University Myunggok Research 2024National Research Foundation of Korea NRF-2021R1G1A1011066
6 · The paper itself

Abstract

Lung cancer remains one of the most common and lethal malignancies worldwide, with poor prognosis largely due to late-stage diagnosis and resistance to therapy. Emerging evidence indicates that long non-coding RNAs (lncRNAs) play critical roles in cancer development, metastasis, and treatment resistance. Particulate matter (PM), a major environmental pollutant and recognized Group 1 carcinogen, has been linked to lung cancer through mechanisms that may involve dysregulation of lncRNA expression. This study aimed to identify PM-responsive lncRNAs in lung cancer, and investigate their potential functional roles. Microarray analysis of lung cancer cell lines A549, H358, H292, and HCC827, exposed to PM10, revealed significant up-regulation of lnc-MTPAP-1. TUNEL staining confirmed that silencing of lnc-MTPAP-1 via siRNA resulted in increased apoptosis across all tested lines. Transcriptome analysis using next-generation sequencing showed that knockdown of lnc-MTPAP-1 altered the expression of apoptosis-related genes, with up-regulation of TNS4, MyD88, and IL6R, and down-regulation of CLPTM1L and EI24. These findings suggest that lnc-MTPAP-1 may exert anti-apoptotic effects in lung cancer cells, and be involved in pollution-induced cancer progression. Further research should explore the therapeutic potential of targeting lnc-MTPAP-1, and better understand the molecular impact of PM exposure on lung cancer pathogenesis.

Indexed as

ApoptosisCarcinoma, Non-Small-Cell LungLung NeoplasmsParticulate MatterRNA, Long NoncodingCell Line, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticHumansParticulate MatterRNA, Long Noncodingapoptosisgene expressionlnc-MTPAP-1long non-coding RNA (lncRNA)lung cancernext-generation sequencing (NGS)particulate matter (PM10)siRNA knockdown

Identifiers

PMID41226525
PMCPMC12608595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.